Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2005-08-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is hypothesized that long term insulin pump therapy initiated during early childhood can delay the progression of neurocognitive complications of diabetes, decrease parental stress, and improve school performance and quality of life, as compared to insulin injections.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes
NCT02848261
Research on Optimizing the Use of Technology With Education
NCT05564481
Personalized Comprehensive Diabetes Support for Children With Newly Diagnosed Type 1 Diabetes
NCT06057662
Neuropsychological Consultation as Part of Pediatric Diabetes Care: Does it Improve Glycemic Control and Family Functioning?
NCT03653013
Self-Management in Young Adults With Type 1 Diabetes
NCT04975230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Insulin Pump Therapy
Children on insulin pumps for at least three years. Subjects must have type 1 diabetes for at least five years and diagnosed under the age of 5.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children recruited on pumps must have used pump therapy for at least 3 years
* Parents/guardians must be understand the protocol and be able to give consent, with assent obtained from all children over the age of 7 years.
Exclusion Criteria
* Children must not have any other chronic illness in addition to diabetes with the exception of treated autoimmune hypothyroidism.
6 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Juvenile Diabetes Research Foundation
OTHER
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda DiMeglio, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda A DiMeglio, MD
Role: PRINCIPAL_INVESTIGATOR
Indiana University/Riley Hospital for Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Riley Hospital for Children
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0507-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.